CARDINAL HEALTH INC
Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.
CAPITALIZATION 6/30/26
| ($ millions) | Amount | % |
|---|---|---|
| Total debt | 8,886 | 148.0 |
| Stockholders' equity | (2,883) | -48.0 |
| Total capitalization | 6,003 | 100.0 |
232,575,728 shares outstanding at 31 July 2026 (cover page of the 10-K filed 11 August 2026).
LONG-TERM DEBT 6/30/26
| ($ millions) | Amount |
|---|---|
| Long-term debt, noncurrent | 7,004 |
| Current maturities | 1,882 |
CAPITAL STOCK 6/30/26
| Common shares authorized | 755,000,000 |
| Common shares issued | 271,000,000 |
| Treasury shares | 38,000,000 |
| Preferred stock ($ millions) | 0 |
| Outstanding at 7/31/26 | 232,575,728 |
DIVIDENDS DECLARED/PAID
| Fiscal year | Per share $ | Payout % |
|---|---|---|
| 2026 | 2.04 | 28.2 |
| 2025 | 2.02 | 31.3 |
| 2024 | 2.00 | 58.0 |
| 2023 | 1.98 | 157.1 |
| 2022 | 1.96 | – |
HISTORY AND BUSINESS
HISTORY: Incorporated in Ohio. Formerly known as CARDINAL DISTRIBUTION INC (to 17 February 1994).
BUSINESS: Classified by the SEC under Standard Industrial Classification 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries. Large accelerated filer. Principal executive office: 7000 Cardinal Place, Dublin, OH 43017. Fiscal year ends June 30. For a description of the business, see Item 1 of the latest 10-K.
CONSOLIDATED INCOME ACCOUNT, YEARS ENDED
| ($ millions) | 6/30/26 | 6/30/25 | 6/30/24 |
|---|---|---|---|
| Revenues | 254,248 | 222,578 | 226,827 |
| Cost of revenues | 244,474 | 214,410 | 219,413 |
| Gross profit | 9,774 | 8,168 | 7,414 |
| Selling, general and administrative | 6,132 | 5,382 | 5,000 |
| Depreciation and amortization | 956 | 790 | 710 |
| Operating income | 2,613 | 2,275 | 1,243 |
| Interest expense | 348 | 215 | 51 |
| Income before income taxes | 2,174 | 2,101 | 1,201 |
| Income taxes | 469 | 532 | 348 |
| Net income | 1,714 | 1,561 | 852 |
| Earned per share, diluted ($) | 7.23 | 6.45 | 3.45 |
| Dividends per share ($) | 2.04 | 2.02 | 2.00 |
CONSOLIDATED BALANCE SHEET
| ($ millions) | 6/30/26 | 6/30/25 |
|---|---|---|
| Cash and equivalents | 4,856 | 3,874 |
| Receivables, net | 13,815 | 13,242 |
| Inventories | 17,297 | 16,831 |
| Total current assets | 38,753 | 36,373 |
| Property, plant and equipment, net | 3,031 | 2,858 |
| Goodwill | 11,442 | 9,691 |
| Total assets | 57,299 | 53,122 |
| Total current liabilities | 43,904 | 38,897 |
| Long-term debt | 7,004 | 7,977 |
| Stockholders' equity | (2,883) | (2,781) |
| Total liabilities and equity | 57,299 | 53,122 |
TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)
| Fiscal year ended | Revenues | Oper. income | Net income | Net margin % | EPS diluted $ | Div. per share $ | Oper. cash flow | Capital expend. | Free cash flow | Total assets | Total liabilities | Total debt | Stockholders' equity | ROE % | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6/30/26 | 254,248 | 2,613 | 1,714 | 0.7 | 7.23 | 2.04 | 5,174 | 649 | 4,525 | 57,299 | 60,023d | 8,886 | (2,883) | -59.5 | -3.08 |
| 6/30/25 | 222,578 | 2,275 | 1,561 | 0.7 | 6.45 | 2.02 | 2,397 | 547 | 1,850 | 53,122 | 55,756d | 8,527 | (2,781) | -56.1 | -3.07 |
| 6/30/24 | 226,827 | 1,243 | 852 | 0.4 | 3.45 | 2.00 | 3,762 | 511 | 3,251 | 45,121 | 48,333d | 5,092 | (3,213) | -26.5 | -1.58 |
| 6/30/23 | 204,979 | 752 | 330 | 0.2 | 1.26 | 1.98 | 2,844 | 481 | 2,363 | 43,349 | 46,306d | 4,701 | (2,958) | -11.2 | -1.59 |
| 6/30/22 | 181,326 | (607) | (938) | -0.5 | (3.37) | 1.96 | 3,175 | 387 | 2,788 | 43,878 | 44,760d | 5,315 | (709) | 132.3 | -7.50 |
| 6/30/21 | 162,467 | 472 | 611 | 0.4 | 2.08 | 1.94 | 2,429 | 400 | 2,029 | 44,453 | 42,830d | 6,236 | 1,791 | 34.1 | 3.48 |
| 6/30/20 | 152,922 | (4,098) | (3,696) | -2.4 | (12.61) | 1.92 | 1,960 | 375 | 1,585 | 40,766 | 38,974d | 6,775 | 1,789 | -206.6 | 3.79 |
| 6/30/19 | 145,534 | 2,060 | 1,363 | 0.9 | 4.53 | 1.91 | 2,722 | 328 | 2,394 | 40,963 | 34,633d | 8,031 | 6,328 | 21.5 | 1.27 |
| 6/30/18 | 136,809 | 126 | 256 | 0.2 | 0.81 | 1.85 | 2,768 | 384 | 2,384 | 39,951 | 33,892d | 9,013 | 6,059 | 4.2 | 1.49 |
| 6/30/17 | 129,976 | 2,120 | 1,288 | 1.0 | 4.03 | 1.80 | 1,184 | 387 | 797 | 40,112 | 33,284d | 11,250 | 6,808 | 18.9 | 1.65 |
Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.
REGISTRANT:
CARDINAL HEALTH INC
CIK 721371 · EIN 31-0958666
PRINCIPAL OFFICE:
7000 Cardinal Place, Dublin, OH 43017
Tel.: 6147573033
INCORPORATED:
Ohio
INDUSTRY (SEC SIC CODE):
5122 · Wholesale-Drugs, Proprietaries & Druggists' Sundries
FILER STATUS:
Large accelerated filer
LATEST ANNUAL REPORT:
10-K for period ended 6/30/26, filed 11 August 2026
FORMER NAMES:
CARDINAL HEALTH INC; CARDINAL DISTRIBUTION INC
Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2026 (filed 8/11/26) · 10-K FY2025 (filed 8/12/25) · 10-K FY2024 (filed 8/14/24) · 10-K FY2023 (filed 8/15/23) · 10-K FY2022 (filed 8/11/22) · 10-K FY2021 (filed 8/16/21) · 10-K FY2020 (filed 8/13/20) · 10-K FY2019 (filed 8/20/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.
Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.